Experience of prophylaxis treatment in children with severe haemophilia-Reference-Cited by-同舟云学术

Experience of prophylaxis treatment in children with severe haemophilia

Published:2002-03 Issue:2 Volume:8 Page:76-82
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

YEE T. T.,BEETON K.,GRIFFIOEN A.,HARRINGTON C.,MINERS A.,LEE C. A.,BROWN S. A.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2516.2002.00630.x/fullpdf

Reference22 articles.

1. Haemophilia in Sweden. VII: Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B;Ahlberg;Acta Orthopaedica Scand,1965

2. UKHCDO Clinical Guidelines: Prophylaxis in the Treatment of Haemophilic Boys 1994

3. Considerations for recurrent and future management of hemophilia and its complications;Lusher;Haemophilia,1995

4. Haemophilia prophylaxis in young patients - a long-term follow-up;Löfqvist;J Intern Med,1997

5. When should prophylactic treatment in patients with haemophilia A and B start? The German experience;Kreuz;Haemophilia,1998

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B‐LONG study;European Journal of Haematology;2024-06-25

2. Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A;Research and Practice in Thrombosis and Haemostasis;2023-01

3. Tailored prophylaxis in children with severe hemophilia: A four-year Iranian study;Transfusion and Apheresis Science;2021-12

4. WITHDRAWN: Primary prophylaxis in haemophilia care: Guideline update 2016;Blood Cells, Molecules, and Diseases;2020-02

5. Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B;Therapeutic Advances in Hematology;2018-10-05